Home/Filings/4/0001736297-25-000117
4//SEC Filing

Gajendra Sanjay 4

Accession 0001736297-25-000117

CIK 0001736297other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 8:30 PM ET

Size

11.1 KB

Accession

0001736297-25-000117

Insider Transaction Report

Form 4
Period: 2025-08-18
Gajendra Sanjay
DirectorPresident and COO
Transactions
  • Sale

    Common Stock

    2025-08-18$183.17/sh44,551$8,160,3982,170,877 total
  • Sale

    Common Stock

    2025-08-18$183.83/sh46,890$8,619,9862,215,428 total
Holdings
  • Common Stock

    (indirect: By Trust)
    695,000
  • Common Stock

    (indirect: By Trust)
    695,000
  • Common Stock

    (indirect: By Trust)
    5,525,545
Footnotes (6)
  • [F1]Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $184.4400 to $183.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $183.4400 to $182.8700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F5]These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F6]These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Issuer

Astera Labs, Inc.

CIK 0001736297

Entity typeother

Related Parties

1
  • filerCIK 0001998179

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 8:30 PM ET
Size
11.1 KB